Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aguulp is a UK-based consumer health company that specializes in liquid nutritional supplements designed for high bioavailability. Co-founded by Stephen Manderson (Professor Green) and Kevin Godlington, the brand focuses on the gut-brain axis to improve overall mental and physical health. The company's product line utilizes liposomal technology, which encapsulates nutrients in fat bubbles to protect them through the digestive system for better absorption. Their core offerings include liquid sachets for gut health, brain function, immunity, and recovery. In 2022, Aguulp was acquired by the e-commerce aggregator The Mothership to support its global expansion and digital presence. The company positions itself at the intersection of wellness and science, targeting health-conscious consumers seeking convenient supplement formats.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aguulp.